Literature DB >> 20962746

The dualistic role of vitamin D in vascular calcifications.

M Shawkat Razzaque1.   

Abstract

Vitamin D is a multifunctional hormone that can affect many essential biological functions, ranging from the immune regulation to mineral ion metabolism. A close association between altered activity of vitamin D and vascular calcification has been reported in various human diseases, including in patients with atherosclerosis, osteoporosis, and chronic kidney disease (CKD). Vascular calcification is a progressive disorder and is a major determinant of morbidity and mortality of the affected patients. Experimental studies have shown that excessive vitamin D activities can induce vascular calcification, and such vascular pathology can be reversed by reducing vitamin D activities. The human relevance of these experimental studies is not clear, as vitamin D toxicity is relatively rare in the general population. Contrary to the relationship between vitamin D and vascular calcification, in experimental uremic models, low levels of vitamin D were shown to be associated with extensive vascular calcification, a phenomenon that is very similar to the vascular pathology seen in patients with CKD. The current treatment approach of providing vitamin D analogs to patients with CKD often poses a dilemma, as studies linked vitamin D treatment to subsequent vascular calcification. Recent genetic studies, however, have shown that vascular calcification can be prevented by reducing serum phosphate levels, even in the presence of extremely high serum 1,25-dihydroxyvitamin D and calcium levels. This article will briefly summarize the dual effects of vitamin D in vascular calcification and will provide evidence of vitamin D-dependent and -independent vascular calcification.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20962746      PMCID: PMC3120050          DOI: 10.1038/ki.2010.432

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  79 in total

1.  Therapeutic potential of klotho-FGF23 fusion polypeptides: WO2009095372.

Authors:  Mohammed S Razzaque
Journal:  Expert Opin Ther Pat       Date:  2010-07       Impact factor: 6.674

2.  Morphological changes of aortal smooth muscle cells exposed to calcitriol in culture.

Authors:  C Tukaj; J Kubasik-Juraniec; M Kraszpulski
Journal:  Med Sci Monit       Date:  2000 Jul-Aug

3.  1,25-dihydroxyvitamin D3 receptor is upregulated in aortic smooth muscle cells during hypervitaminosis D.

Authors:  S Rajasree; P R Umashankar; A V Lal; P Sankara Sarma; C C Kartha
Journal:  Life Sci       Date:  2002-03-01       Impact factor: 5.037

4.  Vitamin D: a pleiotropic hormone.

Authors:  Annemieke Verstuyf; Geert Carmeliet; Roger Bouillon; Chantal Mathieu
Journal:  Kidney Int       Date:  2010-02-24       Impact factor: 10.612

5.  Role of the mouse ank gene in control of tissue calcification and arthritis.

Authors:  A M Ho; M D Johnson; D M Kingsley
Journal:  Science       Date:  2000-07-14       Impact factor: 47.728

6.  Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion.

Authors:  Daniel Zehnder; Rosemary Bland; Ravinder S Chana; David C Wheeler; Alexander J Howie; Mary C Williams; Paul M Stewart; Martin Hewison
Journal:  J Am Soc Nephrol       Date:  2002-03       Impact factor: 10.121

7.  Arterial stiffening and vascular calcifications in end-stage renal disease.

Authors:  A P Guérin; G M London; S J Marchais; F Metivier
Journal:  Nephrol Dial Transplant       Date:  2000-07       Impact factor: 5.992

8.  The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification.

Authors:  Cora Schafer; Alexander Heiss; Anke Schwarz; Ralf Westenfeld; Markus Ketteler; Jurgen Floege; Werner Muller-Esterl; Thorsten Schinke; Willi Jahnen-Dechent
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

9.  Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles.

Authors:  Alexander Heiss; Alexander DuChesne; Bernd Denecke; Joachim Grötzinger; Kazuhiko Yamamoto; Thomas Renné; Willi Jahnen-Dechent
Journal:  J Biol Chem       Date:  2003-01-29       Impact factor: 5.157

10.  1alpha,25-dihydroxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase.

Authors:  Michela C Rebsamen; Jianxin Sun; Anthony W Norman; James K Liao
Journal:  Circ Res       Date:  2002-07-12       Impact factor: 17.367

View more
  39 in total

Review 1.  Osteocalcin: a pivotal mediator or an innocent bystander in energy metabolism?

Authors:  Mohammed Shawkat Razzaque
Journal:  Nephrol Dial Transplant       Date:  2010-12-03       Impact factor: 5.992

Review 2.  Can features of phosphate toxicity appear in normophosphatemia?

Authors:  Satoko Osuka; Mohammed S Razzaque
Journal:  J Bone Miner Metab       Date:  2012-01-05       Impact factor: 2.626

3.  Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans.

Authors:  D J Birmingham; L A Hebert; H Song; W T Noonan; B H Rovin; H N Nagaraja; C Y Yu
Journal:  Lupus       Date:  2012-03-20       Impact factor: 2.911

4.  Genetic induction of phosphate toxicity significantly reduces the survival of hypercholesterolemic obese mice.

Authors:  Mutsuko Ohnishi; Shigeko Kato; M Shawkat Razzaque
Journal:  Biochem Biophys Res Commun       Date:  2011-10-20       Impact factor: 3.575

5.  Markers of bone remodeling are associated with arterial stiffness in renal transplanted subjects.

Authors:  Anne-Sophie Bargnoux; Fernando Vetromile; Nils Kuster; Julie Barberet; Anne-Marie Dupuy; Jean Ribstein; Georges Mourad; Jean-Paul Cristol; Pierre Fesler
Journal:  J Nephrol       Date:  2015-04-29       Impact factor: 3.902

Review 6.  Vascular calcification: When should we interfere in chronic kidney disease patients and how?

Authors:  Usama Abdel Azim Sharaf El Din; Mona Mansour Salem; Dina Ossama Abdulazim
Journal:  World J Nephrol       Date:  2016-09-06

Review 7.  Vitamin D in Cardiovascular Disease.

Authors:  Alkippi Nitsa; Marina Toutouza; Nikolaos Machairas; Anargyros Mariolis; Anastassios Philippou; Michael Koutsilieris
Journal:  In Vivo       Date:  2018 Sep-Oct       Impact factor: 2.155

Review 8.  Effect of race and genetics on vitamin D metabolism, bone and vascular health.

Authors:  Barry I Freedman; Thomas C Register
Journal:  Nat Rev Nephrol       Date:  2012-06-12       Impact factor: 28.314

9.  Dietary and genetic evidence for enhancing glucose metabolism and reducing obesity by inhibiting klotho functions.

Authors:  Mutsuko Ohnishi; Shigeko Kato; Junko Akiyoshi; Azeddine Atfi; M Shawkat Razzaque
Journal:  FASEB J       Date:  2011-03-07       Impact factor: 5.191

Review 10.  Vitamin D in patients with chronic kidney disease: a position statement of the Working Group "Trace Elements and Mineral Metabolism" of the Italian Society of Nephrology.

Authors:  Luigi Francesco Morrone; Pergiorgio Bolasco; Corrado Camerini; Giuseppe Cianciolo; Adamasco Cupisti; Andrea Galassi; Sandro Mazzaferro; Domenico Russo; Luigi Russo; Mario Cozzolino
Journal:  J Nephrol       Date:  2016-04-09       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.